Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study

BACKGROUND: The DYNAGITO study was a Phase IIIb, randomized, double-blind, multicenter, active-controlled, parallel-group, 52-week study designed to determine the efficacy and safety of tiotropium and olodaterol combination therapy (TIO+OLO 5/5 μg) versus tiotropium monotherapy (TIO 5 μg) for reduci...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Chron Obstruct Pulmon Dis
Autors principals: Ichinose, Masakazu, Nishimura, Masaharu, Akimoto, Manabu, Kurotori, Yasuhiro, Zhao, Yihua, de la Hoz, Alberto, Mishima, Michiaki
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Clinical Trial Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6049061/
https://ncbi.nlm.nih.gov/pubmed/30034230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S169941
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars